Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ophthalmic preparation and application thereof in treating presbyopia

An ophthalmic preparation and technology for presbyopia, which is applied in the field of rebamipide and acetone, can solve the problems of presbyopia that have not yet been established with acetone, and achieve the effects of strengthening, delaying long-term progress, and reducing related side effects

Pending Publication Date: 2022-06-07
THE EYE HOSPITAL OF WENZHOU MEDICAL UNIV
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no report on the combined use of acecolidine and rebamipide in the treatment of presbyopia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ophthalmic preparation and application thereof in treating presbyopia
  • Ophthalmic preparation and application thereof in treating presbyopia
  • Ophthalmic preparation and application thereof in treating presbyopia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0091] Example 1 drug combination screening based on target information

[0092]Based on the analysis of the previous literature, it was found that the current presbyopia-related treatment drug mechanisms mainly include: 1) Muscarinic acetylcholine receptor M3 excitation; 2) COX-2 inhibitors; 3) Antioxidant drugs. Pharmacological network model is recommended for drug screening according to key nodes. At the same time, the COX-2 protein structure (PDB: 4PH9) and the muscarinic acetylcholine receptor (PDB:4DAJ) were selected as the key proteins, and the results were combined with the pharmacological network model after virtual screening using the ZINC drug structure database, and the score was based on the weights of the edges in the network. After screening, it was found that rebapirate ranked first among all drugs, and the top twenty molecules in the model included diclofenac (twelfth) and bromfenac (fourth), and so on.

Embodiment 2

[0093] Example 2 Method of preparing an ophthalmic formulation for the treatment of presbyopia

[0094] 1. Method for preparing compositions

[0095] (1) The excipients are dissolved

[0096] (1) Dissolution of carboxymethyl cellulose CMC (McLean: C889437): Take 1 2L beaker to take about 1500mL of ultrapure water at 80 °C, use an LED overhead stirrer to slowly add carboxymethyl cellulose CMC while stirring, stir for about 7h and continue to add other excipients.

[0097] (2) Add sodium chloride NaCl: observe the CMC solution, add sodium chloride after the CMC is completely dissolved, and continue to stir for 10 min.

[0098] (3) Add hydroxypropyl-β-cyclodextrin HPBCD (Bid: BD44359): Slowly add hydroxypropyl-β-cyclodextrin HPBCD and stir until dissolved, stirring for about 1h.

[0099] (4) Add benzalkonium chloride BAK: Benzalkonium chloride BAK is dissolved in about 50mL ultrapure water, and then added to the above CMC solution drop by drop, and continue to stir for 10min.

[0100...

Embodiment 3

[0116] Example 3 animal irritation test

[0117] 1. Experimental methods

[0118]Animal experiments with rabbits as research objects, randomly divided into control group and experimental group #1-#9, for each experimental group, the use of single dose administration, the corresponding number of drugs are given to drop the right eye, each administration is 50 μL, the control group does not administer, the left eye of the experimental group is administered with the same dose of normal saline; Slit lamps were used to check the pupil size at 0min, 10min, 20min, 30min, 1h, 2h, 4h, 6h after a single dose, and the degree of corneal opacity, conjunctival hyperemia, edema and secretion, iris congestion or bleeding were scored according to the Draize stimulation experiment scoring standard at 30min, and the irritation rating was performed. The overall results show that when the eye drops score of the animal eye irritation is less than 3, it can be considered that there is no obvious irritat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an ophthalmic preparation and application thereof in treatment of presbyopia, the ophthalmic preparation comprises acestodine and rebamipide, it is found and proved for the first time that the acestodine and the rebamipide are combined to have a synergistic effect, the rebamipide can enhance the effect of the acestodine and reduce related side effects, and the ophthalmic preparation can be used for treating presbyopia. Vinegar can effectively generate a synergistic effect with rebamipide to contract the pupil sphincter, and the ophthalmic preparation can effectively improve, relieve or treat presbyopia, has a potential effect of delaying the progress of the aging eye course, and has a very good clinical application prospect.

Description

Technical field [0001] The present invention belongs to the field of biomedical technology, in particular, the present invention relates to an ophthalmic formulation and its application in the treatment of presbyopia, more particularly, the ophthalmic formulation of the present invention comprises acecolidine, rebapiter. Background [0002] The body's ability to adjust the eye gradually declines with age, causing patients with myopia difficulties, this phenomenon is called presbyopia (Pb), also known as presbyopia. For a long time, the main methods used to correct vision have been the use of reading glasses or bifocal glasses, as well as contact lenses specially designed for presightly vision, as well as several surgical therapies, including intraocular lens implantation and corneal laser orthopedics. At present, the most widely used is the use of optical lens correction, this type of glasses is suitable for temporary wearing when reading, but during the wearing process can only ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4704A61K45/06A61K47/38A61K47/40A61K9/08A61P27/10A61K31/439A61K31/498
CPCA61K31/4704A61K45/06A61K9/0048A61K47/38A61K47/40A61K9/08A61P27/10A61K31/439A61K31/498A61K2300/00
Inventor 陈蔚
Owner THE EYE HOSPITAL OF WENZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com